Paloma Partners Management CO Moderna, Inc. Put Options Transaction History

Paloma Partners Management CO

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $374,477 - $616,457	3,700 New	3,700 $439,000
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $834,120 - $1.25 Million	-12,000 Reduced 46.33%	13,900 $1.38 Million
Q3 2023 Nov 14, 2023	SELL	$96.41 - $126.61 $993,023 - $1.3 Million	-10,300 Reduced 28.45%	25,900 $2.68 Million
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $1.88 Million - $2.55 Million	15,900 Added 78.33%	36,200 $4.4 Million
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $2.75 Million - $4 Million	20,300 New	20,300 $3.12 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $2.83 Million - $4.66 Million	24,000 New	24,000 $2.84 Million

953

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.